Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.

Saved in:
Bibliographic Details
Title: Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
Authors: Steffanoni S; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Calimeri T; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Laurenge A; Service de Neurologie 2-Mazarin, Hôpitaux Universitaires La Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France., Fox CP; Hematology Department, University Hospitals NHS Trust, Nottingham, UK., Soussain C; Hôpital René Huguenin-Institut Curie, Saint-Cloud, Paris, France., Grommes C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Tisi MC; Division of Hematology, Ospedale San Bortolo, Vicenza, Italy., Boot J; Barking, Havering and Redbridge University Hospitals NHS Trust, London, UK., Crosbie N; Derriford Hospital, Plymouth, UK., Visco C; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy., Arcaini L; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Chaganti S; Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK., Sassone MC; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Alencar A; Department of Hematology and Oncology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida, USA., Armiento D; Division of Hematology, Campus Bio Medico, Rome, Italy., Romano I; Division of Hematology, Ospedale Careggi, Florence, Italy., Dietrich J; Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Itchaki G; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel., Bruna R; Division of Hematology, Ospedale Maggiore, Novara, Italy., Fracchiolla NS; UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Arletti L; Division of Hematology, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy., Venditti A; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Booth S; NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK., Musto P; Department of Emergency and Organ Transplantation, 'Aldo Moro' University School of Medicine, and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy., Hoang Xuan K; Service de Neurologie 2-Mazarin, Hôpitaux Universitaires La Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France., Batchelor TT; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Cwynarski K; Department of Haematology, University College London Hospital, London, UK., Ferreri AJM; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Source: British journal of haematology [Br J Haematol] 2022 Nov; Vol. 199 (4), pp. 507-519. Date of Electronic Publication: 2022 Aug 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2141
DOI:10.1111/bjh.18396